Background: A common genetic basis for IgA deficiency (IgAD) and common variable immunodeficiency (CVID) is suggested by their occurrence in members of the same family and the similarity of the underlying B cell differentiation defects. An association between IgAD/CVID and HLA alleles DR3, B8, and Al has also been documented. In a search for the gene(s) in the major histocompatibility complex (MHC) that predispose to IgAD/CVID, we analyzed the extended MHC haplotypes present in a large family with 8 affected members.
Background: A common genetic basis for IgA deficiency (IgAD) and common variable immunodeficiency (CVID) is suggested by their occurrence in members of the same family and the similarity of the underlying B cell differentiation defects. An association between IgAD/CVID and HLA alleles DR3, B8, and Al has also been documented. In a search for the gene(s) in the major histocompatibility complex (MHC) that predispose to IgAD/CVID, we analyzed the extended MHC haplotypes present in a large family with 8 affected members.
Materials and Methods:
We examined the CVIID proband, 72 immediate relatives, and 21 spouses, and determined their serum immunoglobulin concentrations. The MHC haplotype analysis of individual family members employed 21 allelic DNA and protein markers, including seven newly available microsatellite markers. Results: Forty-one (56%) of the 73 relatives by common descent were heterozygous and nine (12%) were homozygous for a fragment or the entire extended MHC haplotype designated haplotype 1 that induded HLA-DR3, -C4A-0, -B8, and -Al. The remarkable prevalence of haplotype 1 was due in part to marital introduction into the family of 11 different copies of the haplotype, eight sharing 20 identical genotype markers between HLA-DR3 and HLA-B8, and three that contained fragments of haplotype 1. Conclusion: Crossover events within the MHC indicated a susceptibility locus for IgAD/CVID between the Introduction Immunoglobulin (Ig)A deficiency (IgAD), the most frequently recognized primary immunodeficiency, occurs with an incidence of approximately 1 in every 600 individuals of European ancestry (reviewed in refs. 1 and 2). Common variable immunodeficiency (CVID) is the second most common type of primary immune deficiency in European populations (2, 3) . B cells are present in both IgAD and CVID patients, but a variable differentiation defect is seen for plasma cells of the different isotypes (2, 4) . Individuals with CVID are typically panhypogammaglobulinemic, although some produce substantial amounts of IgM, and individuals with IgAD may also be deficient in the IgG subclasses IgG2 and IgG4 (2, 5, 6) . IgAD and CVID thus represent opposite poles of an immunodeficiency spectrum that ranges from selective IgAD to an inability to produce antibodies of any isotype.
IgAD may affect several members of the same family (7) and its incidence is highly variable in different population groups. The prevalence of IgAD among African-Americans is onetwentieth of that seen in European-Americans (8, 9) , and the incidence appears even lower among Japanese (1 in 18,500) (10) . Among Israeli army recruits, the prevalence of IgAD is related to ethnicity, with more recruits of European derivation affected than those of North African, Israeli, or Asian derivation (11) . These differences suggest that genetic factors play a major role in the pathogenesis of IgAD, but the mode of familial transmission is unclear as some pedigrees suggest a pattern of autosomal dominance and others autosomal recessive inheritance (7, 12, 13) . Individuals with either IgAD or CVID can be seen in multiplex families (14) . Coupled with the similarity in clinical phenotype, these observations support the hypothesis that IgAD and CVID reflect a common underlying genetic defect (15) .
In an earlier study, we found that 24 of 31 IgAD and CVID patients in a clinic population, including all of the familial cases within this group, shared either complete copies or extended
The publisher or recipient acknowledges the right of the U.S. government to retain a non-exclusive, royalty-free li (HLA-DQB1 0201, HLA-DR3, C4B-Sf, C4A-0,  G11-15, Bf-0.4, C2-a, HSP-7.5, TNF-5, HLA-B8,  HLA-A1) and haplotype 2 (HLA-DQB1 0201,  HLA-DR-7 , C4B-S, C4A-L, G11-4.5, Bf-0.6, C2-b, HSP-9, TNF-9, HLA-B44, HLA-A29) (16) . These observations confirmed many previous reports of the association of IgAD with HLA-A1, -B8, -DR3, and -C4A-0 (16) (17) (18) (19) (20) (21) (22) (23) (16, 25) . During the course of this extended analysis, 84 relatives with a common ancestry and 33 spouses were identified (Fig. 1) (26) . In selected relatives, a 328 base pair (bp) fragment upstream of TNF-a containing the 5' promoter region was amplified and sequenced by PCR (29) on an ABI 377 Automated Sequencer (Applied Biosystems, Foster City, CA). The TNF locus was analyzed with the TNF-associated DNA microsatellite markers a and b that measure repeat sequences adjacent to the LTA gene. These were genotyped by PCR as previously described (27, 30) . In some relatives, the protein products of HLA-A and -B alleles were typed by the microdroplet lymphocytotoxicity assay (15) , and in others they were DNA typed by the sequence-specific primer amplification method using a Pel-Freez Class I ABC SSP Unitray (Pel-Freez, Brown Deer, WI). The identity of the protein product of the HLA-DR allele was assessed in some family members by the microdroplet lymphocytotoxicity assay (15) and confirmed in others by PCR amplification of a highly polymorphic region of the DRB locus from genomic DNA, followed by blotting and hybridization of sequence-specific radiolabeled oligonucleotide probe specific for the DR3 (Fig. 2 ). These microsatellite markers were fluorescently labeled and detected on an ABI 377 sequencer (Applied Biosystems, Foster City, CA).
Statistical Analysis
Differences in the frequency of study parameters between two populations were assessed by Student's t test, two-tailed, or by binomial probability, one-tailed, when indicated.
Results
More than 90% of the members of the S12 family ( Fig. 1 Of the remaining family members, 1 relative by common descent and 8 spouses underwent MHC polymorphism analysis alone, 2 relatives by common descent and 2 spouses were deceased, and 9 relatives by common descent and 10 spouses declined evaluation. Of the 8 immunodeficient members identified in this family, seven were found to have a complete set of the markers that identify haplotype 1 including the complotype markers C4B-Sf, C4A-0, Bf-O. 4 , and C2-a, as well as HLA-DR3 and HLA-B8 (16) . Only 2 of these individuals inherited haplotype 1 from a common ancestor (SI2.II.II and SI2.III.28). We termed MHC haplotypes that shared identity in all markers between HLA DR3 and B8, but which were derived from unrelated ancestors, "complete" copies of haplotype 1. These were numbered alphabetically a through h. Surprisingly, the eighth immunodeficient relative, SI2.IV.25, who had undetectable levels of serum IgA on three separate occasions, was homozygous for HLA-DR4 and lacked the complotype markers associated with haplotype 1. Analysis of his TNF, HLA-B, and HLA-A loci indicated that this individual was homozygous for TNF-a2b3, HLA-B8, and HLA-AI, all of which are found in haplotype 1. Thus, the patient inherited two incomplete copies, or fragments, of haplotype 1 that retained the markers for TNF and HLA-B at the telomeric end of the haplotype. Neither of these proved to be de novo recombinants. One fragment, designated X' was inherited from the mother. This fragment was also present in 13 additional family members (Fig. 1) . The second fragment, designated Ji, was inherited from the father.
Seven recently described microsatellite markers that span the HLA class III region (28) were used to clarify the relationship between the various copies of haplotype 1 that were derived from unrelated ancestors. All but one of the haplotype 1 copies that shared identical complotypes proved to have identical genotypic markers in the region spanning HLA-DR through HLA-A and thus share identity for the entire class III region ( Table 1 ). The exception, fragment X 3 , lacks HLA-DR3 but shares identity for the microsatellite marker D3A that is positioned between HLA-DR and C4B. Fragment X shares identity with haplotype 1 for HLA-A through the micro satellite marker 823, which is located between the GI and BI44 genes. Fragment Ji shares extensive identity with haplotype 1 between the factor B locus and HLA-A. Within this fragment of the haplotype there are two polymorphic markers that differ between haplotype 1 and Ji. Haplotype 1 contains a 91 allele at microsatellite marker 821 (which is adjacent to the Gl gene) and a 272 allele at the MIB microsatellite marker (which is contained within the MICB gene), whereas fragment Ji has the 93 and 276 alleles, respectively (Fig. 2, Table 1 ). These differences are most likely due to further expansion of the dinucleotide repeats that characterize the markers and suggest that the event that led to the creation of fragment Ji is an ancient one.
The TNF-a allele of the DR3-B8-Al haplotype, our haplotype 1, contains a polymorphic DNA sequence in the 5' promoter region of the gene: the rare substitution of an adenine (TNF-308A) for guanine at position -308 in the presence of the common guanine at position -238 (TNF-238G) (31) . Cells that contain the TNF-308A mutation express more TNF-a than those with the common TNF-308G allele (31, 32) .
Given the lack of identity between fragment Ji and haplotype 1 at the microsatellite markers 821 and MIB, we sought to further clarify the identity of the incomplete haplotype 1 in the TNF region by examination of this region of the TNF gene at the sequence level. A 328 bp fragment containing this region of the TNF-a gene from IgA-deficient individual IV.25 (genotype xlJi) and the CVID proband II.ll (genotype a/x) was PCR amplified and directly sequenced from each patient. The patients proved homozygous for both the TNF-308A and TNF-238G alleles, indicating that the X and Ji fragments share identity with haplotype 1 for these TNF-a markers.
Immunodeficiency Was Found Only in Individuals Having the GI-HLA-A Portion of Haplotype 1
Of the 73 family members who share descent from a common ancestor (Fig. 1), 33 have one complete copy of haplotype 1 from the region between HLA·DR3 and C4A through HLA-A (Fig. 2) . Of these, four are immunodeficient (12%). Two individuals who are homozygous for complete copies of haplotype 1 have normal se- II  II  II  III  II  III  III  IV  IV  III  III  III  II  II  II  III  II  III The higher-than-expected prevalence of haplotype 1 in this family led us to investigate the pattern of parental transmission. The parents of proband S 12JI. 11. are deceased and the paternal uncle did not share a complete haplotype with the proband or his siblings, thus we were unable to assign parental transmission for generation II. However, including spouses, there were 11 mothers with one complete copy of haplotype 1 who married men without a complete copy of haplotype 1 . Of the 23 children tested, 17 inherited and 6 did not inherit haplotype 1 (p = 0.03, binomial probability, two-tailed). There were 3 mothers with complete copies of haplotype 1 whose husbands also had a complete copy of haplotype 1 . Of the 11 children tested, 10 (91%) inherited at least one copy of haplotype 1. Although the percentage is high, the number of children was insufficient to reach statistical significance. Fragment X3 lacks HLA-DR3 but shares identity with other copies of haplotype 1 in the remaining class II and class I markers. Of the 3 children of the mother with fragment X3' one inherited the copy and two did not. However, her husband also has a complete copy of haplotype 1, and two of her children inherited the full copy. There were 5 mothers with a copy of the X fragment. Of their 8 25 and this report), and improvement from IgA deficiency to normal IgA serum concentrations over a 2-year period in a young infant (S12.IV.37, this report). The variation in clinical phenotype raises the possibility that IgAD/CVID reflects quantitative and potentially reversible changes in lymphocyte function. The fluctuations that may occur in immunoglobulin serum concentrations also complicate the genetic analysis of these disorders.
Previous studies of the genetics of IgAD and CVID have suggested an autosomal recessive pattern of inheritance in some families, and autosomal dominant transmission in others (7, 12, 13, 44) . Several studies have now documented a higher-than-expected prevalence of haplotype 1 in IgAD/CVID patients (15) (16) (17) (18) (19) (20) (21) (22) (23) 25) . When individuals selected on the basis of homozygosity for haplotype 1 were evaluated, 13 % (7 of 54) proved to be IgA-deficient compared with the estimated prevalence of 0.17%, approximately a 75-fold increase (16, 17, 33) . Cosegregation of immunodeficiency and a large panel of MHC genetic markers indicate that all of the immunodeficient individuals in the S12 family share at a minimum a common fragment of haplotype 1. Conversely, Vorechovsky et al. (45) failed to demonstrate close linkage between the MHC region and inheritance of IgAD and CVID using an autosomal inheritance model with incomplete penetrance and phenocopies, and sibpair analysis. Several differences in study design may contribute to differences in the conclusions reached in these studies. Whereas the Vorechovsky studies involved two-and three-generation families from several European communities, the present study was of a single large family, thereby reducing the risk of genetic heterogeneity that may complicate linkage analysis. In our pedigree, a much higher risk was observed for individuals homozygous for the susceptibility locus within haplotype 1 than for individuals who are heterozygous. This suggests that the autosomal dominant model may not apply here, and misspecification of the transmission model would tend to inflate the recombination fraction in a linkage analysis (46) . The genetic markers employed in the present study were designed to cover the entire MHC region, and the use of these markers was essential for the identification of the immunodeficiency phenotype association with genes in a subregion of the MHC class I1l region. By comparison, only two of the genetic markers employed in the Vorechovsky study were located within the MHC region-the DQ0357 codon marker and the D6S273 microsatellite, the latter being closest to our microsatellite 822. Significantly, both of these markers lie outside the candidate area identified in the present study.
A central tenet of the existence of ancestral or extended haplotypes holds that any locus within a particular ancestral haplotype should have identity in genetic content with similar ancestral haplotypes from individuals who are not obviously related by common descent from a recent ancestor (47) . By extension, fragments of the ancestral haplotype would also be expected to share genetic content in the region bounded by that fragment. In the S12 family, different copies and even fragments of haplotype 1 appear interchangeable in enhancing the risk for IgAD/ CVID. The interchangeability of the different copies of haplotype 1 in this family implies that the mutation that permits development of immunodeficiency is an ancient one and does not reflect recent alteration of a gene that influences lymphocyte function. Since all individuals with the HLA-DR3, -B8, -Al haplotype carry an enhanced risk for the development of immunodeficiency, haplotype 1 meets the definition of a susceptibility locus, i.e., encoding a gene or genes that increase susceptibility for the development of disease rather than causing the disorder directly (48) .
Through analysis of the fragments of haplotype 1 in affected individuals it is possible to define the susceptibility locus more precisely. In a previous study (16) , we identified two patients with CVID who shared all seven polymorphic markers tested in the class III region, including C4B and TNF, but lacked several of the class I and class II alleles characteristic of haplotype 1. One individual had HLA-B8, but lacked HLA-DR3 and HLA-A1. The second had an even smaller fragment of haplotype 1 and lacked not only HLA-DR3 and HLA-A1 but also HLA-B8. This suggested that the boundaries for the susceptibility locus for haplotype 1 lay between TNF and HLA-B on the telomeric class I end of the MHC, and between C4B and DR on the centromeric class II end. Other studies suggested an IgAD/ CVID association with class II MHC genes, specifically HLA-DQB 1 (18, 23) . However, a recent study of Sardinians homozygous for a crossover HLA-DR3 haplotype yielded evidence against an IgAD/CVID susceptibility locus within the class II region (49) . The Sardinian and North European HLA-DR3 haplotypes share the same HLA-DRB1, DQA1, and DQB1 alleles, but they differ in the class III and I regions starting from the HLA-DRB3 locus apparently because of an ancestral crossover event. Both haplotypes have class II susceptibility genes for insulin-dependent diabetes mellitus (IDDM) and celiac disease (50) , but analysis of 43 individuals homozygous for this Sardinian haplotype failed to identify any with IgAD/CVID. In our family study, the high prevalence of immunodeficiency among individuals homozygous for fragments of haplotype 1 bounded by the microsatellite markers 821/823 and HLA-A1, and IgAD in a family member who lacks the class II region of haplotype 1, further excludes class II genes as susceptibility loci for IgAD/CVID. Our previous study (16) (56) (57) (58) (59) (60) . LT-a and LT-,B knock-out mice have normal serum IgM concentrations but are IgAdeficient (58, 59) . LT-a knock-out mice also demonstrate an inability to produce antigen-specific IgG in either primary or secondary responses (61) . TNF-a knock-out mice lack splenic primary B cell follicles and germinal centers (58, 62) . The serum IgA profile has not been reported in these mice, but IgG antibody immune responses are impaired. Exposure to LT-3-Ig fusion proteins, but not TNFR-Ig, disrupts the normal development of lymphoid tissue architecture, thus indicating a requirement of the interaction between the surface LT-a/f3 complex and its native receptor (57) . Thus, abrogation of the function of these class III region genes can lead to IgAD or hypogammaglobulinemia in mice. Finally, polymorphisms in the TNF-a gene correlate with murine resistance to the development of toxoplasmic encephalitis (63) and influence delayed-type hypersensitivity reactions (64) , which suggests that even moderate differences in gene expression can alter immune responsiveness.
In humans, the alleles of TNF-a and LT-a that form part of haplotype 1 are characterized by five nucleotide differences in the exonic, intronic, and proximal promoter regions from other alleles. Polymorphisms for LT-fB have not yet been described, although the high frequency of polymorphisms in the other genes that comprise haplotype 1 raises the possibility that the genetic composition of the LT-f3 gene may also differ. The promoter for TNF-a in haplotype 1 contains a guanine at position -238 (29) and an adenine at position -308 (65) . The LT-a gene has a silent adenine for guanine substitution in exon 1 at position 87, a guanine for adenine substitution in intron 1 that creates an NcoI site, and a substitution of adenine for cytosine at position 800 in exon 2 that results in the replacement of threonine by asparagine (66) . The TNF-308A polymorphism is associated with enhanced production of both TNF-a and LT-a (31, (67) (68) (69) and with increased susceptibility to cerebral malaria (70) , although the mechanisms that underlie the increase in TNF production and the association with disease susceptibility remains unclear (31, (71) (72) (73) . In support of the hypothesis that differences in TNF expression can influence the immune response, recent studies of TNF-a knock-out mice indicate that heterozygous (+ /-) mice, which lack one copy of the functional TNF gene, show increased susceptibility to high-dose lipopolysaccharide (LPS) lethality, increased susceptibility to challenge with Candida, and delayed resolution of C. parvum-induced inflammation (74) . Similar findings have been reported for double TNF/LT-a-deficient mice (75 Analysis of the patterns of inheritance of immunodeficiency in this family suggests that IgAD and CVID are not attributable solely to a simple Mendelian trait. In the general population, individuals homozygous for the susceptibility locus are at high risk (7 of 54, or 13%) for immunodeficiency. In our family study, the prevalence of immunodeficiency in the S12 family for haplotype 1 heterozygous individuals (4 of 41, or 10%) is equivalent to the risk for haplotype 1 homozygous individuals selected at random from the general population (16, 17, 33) . The risk for family members who are homozygous (4 of nine, or 44%) is 4-fold greater than homozygous individuals in the general population or heterozygous family members. This suggests an additive effect of the susceptibility locus. The increased prevalence of disease in family members when compared with members of the general population also suggests that factors in addition to MHC haplotype are contributing to immunodeficiency. Male-to-male transmission of immunodeficiency is well documented in this family, thus a second genetic factor could be transmitted as an autosomal dominant trait that requires the presence of the susceptibility locus on haplotype 1 for development of the disease. Under this scenario, we may identify 6 obligate carriers of a putative second gene not linked to the MHC. Three (S12.ll.7, S12.III.20, and S12.III.21) of these potential obligate carriers lack haplotype 1. Two (S12.II.5 and S12.III.12) contain a fragment (X) and one (S12.II.4) contains a complete copy of haplotype 1. All 6 of these potential obligate carriers, including those with the susceptibility MHC haplotype, had normal immunoglobulin serum concentrations at the time of evaluation. As an alternative explanation, environmental factors could be the source of the increased risk, a view supported by the fluctuations in serum immunoglobulins observed in affected individuals. The development of disease in different generations would require the environmental factor to be either recurrent or common. Affected family members live within 25 miles of each other, so it is indeed possible that each has been exposed to the same environmental agent. Identification of the MHC gene(s) predisposing to development of the IgAD/CVID spectrum of immunodeficiencies may allow the elucidation of additional genetic or environmental factors.
The 8 blood relatives with subnormal serum immunoglobulin isotype concentrations span the spectrum of immunodeficiency from partial IgA deficiency to complete IgA deficiency to IgA deficiency with IgG subclass deficiencies to CVID. Although not all family members share the identical haplotype by common descent, all affected individuals have inherited at a minimum a fragment of haplotype 1 bounded by the microsatellite markers 821/823 at the class II terminus and HLA-A at the class I terminus. Homozygosity for the 821/823:HLA-A portion of haplotype 1 increased the prevalence of immunodeficiency in family members 4-fold. A susceptibility locus for IgAD/CVID thus appears to exist within a fragment of the HLA-DR3, -B8, -Al haplotype that contains only 21 known genes. Included within this locus are the genes for TNF-a, LT-a, and LT-,B, the alteration of which is associated with immunoglobulin deficiencies in mice. It will therefore be of great interest to explore the possibility that altered function of the TNF-a and LT-a genes due to known mutations of the promoter region or as yet undiscovered mutations of LT-f3 increases susceptibility for immunodeficiency in conjunction with other environmental or genetic factors in humans.
